Association between 49 infant gene polymorphisms and preterm delivery

American Journal of Medical Genetics, Part A

Volumn 143, Issue 17, 2007, Pages 1990-1996

  Chen, Brian H ^a   Carmichael, Suzan L ^a,c   Shaw, Gary M ^a   Iovannisci, David M ^b   Lammer, Edward J ^b  

^a March of Dimes Birth Defects Foundation   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c California Birth Defects Monitoring Program   (United States)

Author keywords

Genes; Preterm delivery; Smoking

Indexed keywords

FOLIC ACID; GENOMIC DNA; HOMOCYSTEINE;

ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; CASE CONTROL STUDY; CELL INTERACTION; CLEFT LIP PALATE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FOLATE METABOLISM; FREQUENCY DISCRIMINATION; HETEROZYGOTE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS; WILD TYPE; XENOBIOTIC METABOLISM; ADULT; AMINO ACID METABOLISM; CONFIDENCE INTERVAL; DNA EXTRACTION; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GSTT1 GENE; GTSP1 GENE; INFLAMMATION; MALE; NAT1 GENE; NAT2 GENE; NORMAL HUMAN; RISK ASSESSMENT; SMOKING; THROMBOPHILIA; UNITED STATES;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; POLYMORPHISM, GENETIC; PREGNANCY; PREMATURE BIRTH;

EID: 34548349215     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31868     Document Type: Article

References (29)

1. Adams KM, Eschenbach DA. 2004. The genetic contribution towards preterm delivery. Semin Fetal Neonatal Med 9:445-452.
2. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Michalek AM, Laughlin R, Nemoto T, Gillenwater KA, Harrington AM, Shields PG. 1996. Cigarette smoking, N-Acetyltransferase 2 genetic polymorphisms, and breast cancer. JAMA 276:1494-1501.
3. Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, Bardy P, McDonald HM. 2004. Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: Risk of preterm birth. Am J Obstet Gynecol 191:2056-2067.
4. Brown KS, Cook M, Hoess K, Whitehead AS, Mitchell LE. 2004. Evidence that the risk of spina bifida is influenced by genetic variation at the NOS3 locus. Birth Defects Res A Clin Mol Teratol 70:101-106.
5. Carmichael SL, Nelson V, Shaw GM, Wasserman CR, Croen LA. 2003. Socio-economic status and risk of conotruncal heart defects and orofacial clefts. Paediatr Perinat Epidemiol 17:264-271.
6. Chen DF, Hu YH, Yang F, Wu BY, Chen L, Fang ZA, Wang LH. 2004. Mother's and child's methylenetetrahydrofolate reductase C677T polymorphism is associated with preterm delivery and low birth weight. Beijing Da Xue Xue Bao 36:248-253.
7. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, Chen JJ, Pullinger CR, Malloy MJ, Siest G, Kane JP. 1999. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 9:936-949.
8. Chwalisz K, Garfield RE. 1998. Role of nitric oxide in the uterus and cervix: Implications for the management of labor. J Perinat Med 26:448-457.
9. Crider KS, Whitehead N, Buus RM. 2005. Genetic variation associated with preterm birth: A HuGE review. Genet Med 7:593-604.
10. Croen LA, Shaw GM, Jensvold NG, Harris JA. 1991. Birth defects monitoring in California: A resource for epidemiological research. Paediatr Perinat Epidemiol 5:423-427.
11. Engel SA, Erichsen HC, Savitz DA, Thorp J, Chanock SJ, Olshan AF. 2005. Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms. Epidemiology 16:469-477.
12. Glueck CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, Sieve-Smith L, Tracy T. 2000. The 4G/4G polymorphism of the hypofibrinolytic plasmingen activator inhibitor type 1 gene: An independent risk factor for serious pregnancy complications. Metabolism 49:845-852.
13. Hamilton BE, Martin JA, Sutton PD. 2004. Births: Preliminary data for 2003. Natl Vital Stat Rep 53:1-17.
14. Hao K, Wang X, Niu T, Xu X, Li A, Chang W, Wang L, Li G, Laird N, Xu X. 2004. A candidate gene association study on preterm delivery: Application of high-throughput genotyping technology and advanced statistical methods. Hum Mol Genet 13:683-691.
15. Hartel C, von Otte S, Koch J, Ahrens P, Kattner E, Segerer H, Moller J, Diedrich K, Gopel W. 2005. Polymorphisms of haemostasis genes as risk factors for preterm delivery. Thromb Haemost 94:88-92.
16. Infante-Rivard C, Rivard GE, Yotov WV, Genin E, Guiguet M, Weinberg C, Gauthier R, Feoli-Fonseca JC. 2002. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 347:19-25.
17. Iovannisci DM. 2000. Highly efficient recovery of DNA from dried blood using the MasterPure™ complete DNA and RNA purification kit. Epicentre Forum 7:6-8.
18. Lammer EJ, Shaw GM, Iovannisci DM, Van Waes J, Finnell RH. 2004. Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms. Epidemiology 15:150-156.
19. Landau R, Xie HG, Dishy V, Stein CM, Wood AJ, Emala CW, Smiley RM. 2002. beta2-Adrenergic receptor genotype and preterm delivery. Am J Obstet Gynecol 187:1294-1298.
20. Menon R, Merialdi M, Betran AP, Dolan S, Jiang L, Fortunato SJ, Williams S. 2006. Analysis of association between maternal tumor necrosis factor-α promoter polymorphism (-308), tumor necrosis factor concentration, and preterm birth. Am J Obstet Gynecol 195:1240-1248.
21. Nukui T, Day RD, Sims CS, Ness RB, Romkes M. 2004. Maternal/newborn GSTT1 null genotype contributes to risk of preterm, low birthweight infants. Pharmacogenetics 14:569-576.
22. Nurk E, Grethe ST, Refsum H, Ueland PM, Vollset SE. 2004. Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: The Hordaland Homocysteine Study. Am J Med 117:26-31.
23. Ozkur M, Dogulu F, Ozkur A, Gokmen B, Inaloz SS, Aynacioglu AS. 2002. Association of the Gln27Glu polymorphism of the beta-2-adrenergic receptor with preterm labor. Int J Gynaecol Obstet 77:209-215.
24. Panahloo A, Mohamed-Ali V, Lane A, Green F, Humphries SE, Yudkin JS. 1995. Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene. Diabetes 44:37-42.
25. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. 1995. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 59:536-545.
26. Shaw GM, Wasserman CR, Lammer EJ, O'Malley CD, Murray JC, Basart AM, Tolarova MM. 1996. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet 58:551-561.
27. Shaw GM, Liberman RF, Todoroff K, Wasserman CR. 1997. Low birth weight, preterm delivery, and periconceptional vitamin use. J Pediatr 130:1013-1014.
28. Tornblom SA, Maul H, Klimaviciute A, Garfield RE, Bystrom B, Malmstrom A, Ekman-Ordeberg G. 2005. mRNA expression and localization of bNOS, eNOS and iNOS in human cervix at preterm and term labour. Reprod Biol Endocrinol 3:33.
29. Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, Niu T, Wise PH, Bauchner H, Xu X. 2002. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 287:195-202.